NOVOS

Unclaimed Page

This company has not been claimed yet by the founder or representative. Claim this business if it is yours to view business statistics, receive messages, etc.

Categories

Contact request

Contact us to learn more about our services, pricing, timelines, and how we can support your goals.

Request

Contact Information

Phone

Unknown

Location

Unknown

Socials

Work at NOVOS? Request access to edit

About

NOVOS Labs is a science-driven longevity supplement company focused on developing clinically researched formulations designed to target the biological mechanisms of aging. The company's flagship product, NOVOS Core Clinical, is a multi-ingredient longevity supplement formulated to address the 12 recognized Hallmarks of Aging, including cellular energy production, cognitive resilience, skin structure and elasticity, blood flow, and vascular health. Unlike many competitors in the supplement space, NOVOS Labs distinguishes itself through a rigorous, evidence-first development process backed by over seven years of research and development. NOVOS Core Clinical has been evaluated in randomized, double-blind, placebo-controlled human clinical trials — a rare standard for dietary supplements — with statistically significant results observed across validated cardiovascular biomarkers relevant to aging research. Clinical outcomes include improvements in endothelial function, arterial flexibility, and systolic blood pressure support, with effect sizes comparable to structured exercise regimens and established dietary interventions such as the Mediterranean and DASH diets. The product has also been validated through preclinical lifespan studies in animal models, where the formulation was found to extend lifespan by more than 18%, as well as through cellular mechanism studies on human cells. NOVOS Labs has achieved notable institutional recognition, with its products available at the Mayo Clinic Store and Bumrungrad International Hospital, ranked among Newsweek's Top 100 Global Hospitals. The formulation is recommended by more than 1,500 physicians and clinicians worldwide. Customer adoption is substantial, with over 10 million servings taken and a loyal base of long-term users, along with a 4.8-star rating based on more than 1,330 reviews. The company targets health-conscious consumers, longevity-focused individuals, and clinicians seeking evidence-based supplement options. NOVOS Labs also utilizes epigenetic biological age testing, specifically the DunedinPACE algorithm measuring DNA methylation biomarkers, to assess the real-world impact of its products on the pace of biological aging. The brand operates at the intersection of cutting-edge aging science and consumer health, positioning itself as a premium, research-validated option in the rapidly growing longevity and healthy aging supplement category.

Services & Capabilities

Longevity Supplement Formulation, Human Clinical Trial Validation, Preclinical Research, Epigenetic Age Testing, Multi-Ingredient Complex Development, Retail Distribution, Clinician-Recommended Products

News

Company News

This section is pulled from articles or press releases that mention your company on BevNET.com and it's not editable by users.

This company has not added news yet.

Have news you want to include?

Submit a press release to share news about new products, services, and company announcements.

Submit News

Press Releases

Company News

This section is pulled from articles or press releases that mention your company on BevNET.com and it's not editable by users.

This company has not added news yet.

Have news you want to include?

Submit a press release to share news about new products, services, and company announcements.

Submit News

Recently Posted Jobs

This company has not added jobs yet.

Recently Posted Jobs

Job Listings

This section is pulled from jobs that have been posted for your company on BevNET.com and it's not editable by users.

This company has not added jobs yet.

Have jobs you want to include?

Submit a job listing and find qualified candidates for your current job opening.

Submit a Listing

Investment & Funding

The Nombase Funding database has 7,925 records from over 2,599 companies.

There’s no funding data for this company.

Investment & Funding

Investment & Funding

This section displays read-only investment and funding data from BevNET.com based on public sources.

The Nombase Funding database has 7,925 records from over 2,599 companies.

More Like NOVOS